Merck shares rose alongside Moderna's following positive phase 3 trial results for their joint cancer vaccine.
Source Post
The creator reviews major financial news from the week, including rising bond yields, a Meta settlement, an...
Sep 3, 2026
The creator reviews major financial news from the week, including rising bond yields, a Meta settlement, and Nvidia's strong earnings report, while highlighting the broader implications for the AI trade.
Linked Mentions
Tickers discussed in this post
Moderna's stock surged following positive phase 3 trial results for its personalized mRNA cancer vaccine.
Nvidia reported massive quarterly revenue of $96 billion, driven by AI data center demand.
Meta's stock rose despite an $18 billion settlement, as the market reacted positively to the news.
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.